|
Report Date : |
16.03.2012 |
IDENTIFICATION DETAILS
|
Name : |
GB PHARMA LIMITED |
|
|
|
|
Registered Office : |
87
Osu Estate Opp. Osu Police Station, Accra, P. o. Box 18100 GPO Accra |
|
|
|
|
Country : |
Ghana |
|
|
|
|
Date of Incorporation : |
06.12.2002 |
|
|
|
|
Legal Form : |
Limited Corporation |
|
|
|
|
Line of Business : |
Distributors of
Pharmaceutical Products |
|
|
|
|
No. of Employees : |
20 Employees |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
USD 50,000 |
|
|
|
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
No complaints |
|
|
|
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – September 30, 2011
|
Country Name |
Previous Rating (30.06.2011) |
Current Rating (30.09.2011) |
|
Ghana |
B2 |
B2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
|
Registered Name: |
GB PHARMA
LIMITED |
||||
|
Requested Name: |
GB PHARMA LIMITED |
||||
|
Other Names: |
None |
||||
ADDRESS AND TELECOMMUNICATION
|
|||||
|
Physical Address: |
87
Osu Estate Opp. Osu Police Station, Accra |
||||
|
Postal Address: |
P.
o. Box 18100 GPO |
||||
|
|
Accra |
||||
|
Country: |
Ghana |
||||
|
Phone: |
233-21-785713/786260 |
||||
|
Fax: |
233-21-786260 |
||||
|
Email: |
|||||
|
Website: |
|||||
CREDIT OPINION
|
|
||||
|
Financial Index as of
December 2011 shows subject firm with a medium risk of credit. However, bank
and credit information obtained reveal a history of prompt payments. We
recommend Credit of USD 50,000 on 90 days. |
|||||
LEGAL
|
|
||||
|
Legal Form: |
Limited Corporation |
||||
|
Date Incorporated: |
6-Dec-2002 |
||||
|
Reg. Number: |
Accra, Ghana |
||||
|
Nominal Capital |
GHS.
100,000 |
||||
|
Subscribed Capital |
GHS.
100,000 |
||||
|
Subscribed Capital is Subscribed in the following form: |
|||||
|
|
Position |
Shares |
|||
|
Dr. Rameshdhar J. Shukla |
Country
Head |
|
|||
|
GB PHARMA UK |
Holding
Company |
|
|||
RELATED COMPANIES
|
|
||||
|
GB PHARMA UK |
Parent company. |
||||
|
None |
Subsidiary company. |
||||
|
None |
Affiliated company. |
||||
|
None |
Shareholder of subject
firm. |
||||
|
None |
Branches of the firm |
||||
OPERATIONS
|
|||||
|
Registered to operate as
distributors of pharmaceutical products |
|||||
|
Imports: |
Asia, Europe, UK |
||||
|
Exports: |
None |
||||
|
Trademarks: |
None |
||||
|
Terms of sale: |
Cash (40%) and 25-90 days (60%), invoices. |
||||
|
|
|
||||
|
Main Customers: |
firms and organizations |
||||
|
Employees: |
20 employees. |
||||
|
Vehicles: |
Several motor vehicles. |
||||
|
Territory of sales: |
Ghana |
||||
|
Location: |
Rented premises, 2,000 square feet, |
||||
AUDITORS AND INSURANCE
|
|
||||
|
Auditors: |
Information not
available. |
||||
|
Insurance Brokers: |
Information not
available. |
||||
|
|
|
||||
FINANCE
|
|
||||
|
Currency Reported: |
Ghanaian Cedi (GHS.) |
||||
|
Approx. Ex. Rate: |
1 US Dollar = 1.72
Ghanaian Cedi |
||||
|
Fiscal Year End: |
December 31, 2011 |
||||
|
Inflation: |
According to information given by independent sources, the inflation
at December 31st, 2011 was of 13%. |
||||
|
|
|||||
|
Financial Information not
Submitted |
|
||||
|
Profit and Loss
(expressed in GHS.) |
|||||
|
|
2010 |
2011 |
|||
|
Sales |
40,000,000 |
43,500,000 |
|||
BANK
|
|
||||
|
Bank Name: |
Barclays
Bank |
||||
|
Branch: |
Accra,
Ghana |
||||
|
Comments: |
None |
||||
TRADE REFERENCES
|
|
||||
|
Experiences: |
Good |
||||
|
|
|
||||
|
NOTARIAL BONDS |
None |
||||
COMMENTS / ADDITIONAL INFORMATION
|
|
||||
|
This information was
obtained from outside sources other than the subject company itself and
confirmed the above subject. |
|||||
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.50.31 |
|
|
1 |
Rs.79.04 |
|
Euro |
1 |
Rs.65.82 |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.